Carestream Molecular Imaging Offers Custom Conjugation Services for its KODAK X-SIGHT Imaging Agents

WASHINGTON, D.C., Nov. 15 — Carestream Molecular Imaging, a division of Carestream Health, Inc., has begun providing custom conjugation services for its KODAK X-SIGHT Nanospheres and Large Stokes Shift Dyes. The new chemistry services are performed by scientists using expert conjugation techniques that deliver personalized bioconjugation of biomolecules to some of the brightest imaging agents on the market.

The conjugation services include labeling of proteins, peptides and antibodies with the company’s fluorescent nanoparticles and dyes, enabling researchers to conduct in vitro and in vivo imaging experiments. “This process can be complex and time-consuming for those unfamiliar with the process or with biomolecules that are difficult to label,” explained Stephanie Chiang, Worldwide Director, Imaging Agent Business, Carestream Molecular Imaging.

“Our skilled scientists use cutting-edge techniques that enhance and standardize the performance of the conjugated biomolecule.”

The process for this service is fast, easy and confidential: Customers submit a form available on the company’s website, send in their protein or peptide, and receive the conjugate in as few as three weeks. The service is personalized, with small- and large-scale production quantities available. It is offered for a wide array of biomolecules, which can be labeled with a selection of extremely bright and biocompatible nanoparticles or the only commercially available large Stokes shift dyes with near IR emission designed to maximize the fluorescent signal while minimizing auto-fluorescence.

For More Information

Custom conjugation services from Carestream Molecular Imaging are now available. For more information, visit http://mistore.carestreamhealth.com or call 1-877-747-4357, express code 7. Outside the United States, call 1-203-786-5657.

Carestream Health, an independent company, has licensed the KODAK brand for use with its own brands across its portfolio of leading-edge molecular imaging, medical imaging and healthcare IT products.

MORE ON THIS TOPIC